医学
脂肪肝
专家意见
疾病
药物治疗
重症监护医学
内科学
作者
Iwona Gorczyca-Głowacka,Marcin Wełnicki,Artur Mamcarz,Krzysztof J Filipiak,Beata Wożakowska-Kapłon,Marcin Barylski,Filip M Szymański,Jarosław D Kasprzak,Krzysztof Tomasiewcz
出处
期刊:Kardiologia Polska
[Polskie Towarzystwo Kardiologiczne]
日期:2023-02-28
卷期号:81 (2): 207-214
标识
DOI:10.33963/kp.a2023.0022
摘要
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients’ prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI